CN102007108A - 趋化因子受体CxCR3的抑制剂 - Google Patents
趋化因子受体CxCR3的抑制剂 Download PDFInfo
- Publication number
- CN102007108A CN102007108A CN2009801138321A CN200980113832A CN102007108A CN 102007108 A CN102007108 A CN 102007108A CN 2009801138321 A CN2009801138321 A CN 2009801138321A CN 200980113832 A CN200980113832 A CN 200980113832A CN 102007108 A CN102007108 A CN 102007108A
- Authority
- CN
- China
- Prior art keywords
- compound according
- resin
- dmf
- replaces
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- SRAWVJVPKDOSJQ-UHFFFAOYSA-N CC(Cc(cc1)ccc1Cl)NC(c(cc1)cc(NC(c2ccc[s]2)=O)c1N1CCN(CCN(C)C)CC1)=O Chemical compound CC(Cc(cc1)ccc1Cl)NC(c(cc1)cc(NC(c2ccc[s]2)=O)c1N1CCN(CCN(C)C)CC1)=O SRAWVJVPKDOSJQ-UHFFFAOYSA-N 0.000 description 1
- RLWKNHICPQLFSY-UHFFFAOYSA-N CCN(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O Chemical compound CCN(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O RLWKNHICPQLFSY-UHFFFAOYSA-N 0.000 description 1
- GZMWWZBSMGACGA-UHFFFAOYSA-N CN(C)CCC(N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cccc(C(O)=O)c1)=O)=O Chemical compound CN(C)CCC(N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cccc(C(O)=O)c1)=O)=O GZMWWZBSMGACGA-UHFFFAOYSA-N 0.000 description 1
- AIRYGLYMGRNXLK-UHFFFAOYSA-N CN(C)CCN(CC1)CCN1c(ccc(C(NCCc(cccc1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O Chemical compound CN(C)CCN(CC1)CCN1c(ccc(C(NCCc(cccc1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O AIRYGLYMGRNXLK-UHFFFAOYSA-N 0.000 description 1
- AHTBAGDMSBHMMO-UHFFFAOYSA-N CN(C)CCN(CC1)CCN1c(ccc(C(NCCc(cccc1)c1F)=O)c1)c1NC(c1cc(Cl)ccc1)=O Chemical compound CN(C)CCN(CC1)CCN1c(ccc(C(NCCc(cccc1)c1F)=O)c1)c1NC(c1cc(Cl)ccc1)=O AHTBAGDMSBHMMO-UHFFFAOYSA-N 0.000 description 1
- FIEKCBNMHDCYHV-UHFFFAOYSA-N CN(C)CCN(CC1)CCN1c(ccc(C(NCCc1cccc(Cl)c1)=O)c1)c1N Chemical compound CN(C)CCN(CC1)CCN1c(ccc(C(NCCc1cccc(Cl)c1)=O)c1)c1N FIEKCBNMHDCYHV-UHFFFAOYSA-N 0.000 description 1
- AQYKMPWZWGIMAZ-LOSJGSFVSA-N CN(C)CCN(CC1)CCN1c(ccc(C(N[C@H](C1)[C@@H]1c1ccccc1)=O)c1)c1NC(c1c[s]cc1)=O Chemical compound CN(C)CCN(CC1)CCN1c(ccc(C(N[C@H](C1)[C@@H]1c1ccccc1)=O)c1)c1NC(c1c[s]cc1)=O AQYKMPWZWGIMAZ-LOSJGSFVSA-N 0.000 description 1
- REZRGVCSIGDUCQ-UHFFFAOYSA-N CN(CC1)CCC1N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O Chemical compound CN(CC1)CCC1N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O REZRGVCSIGDUCQ-UHFFFAOYSA-N 0.000 description 1
- KKPGZOBSPZNVBF-UHFFFAOYSA-N COCCN(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cccc(Cl)c1)=O Chemical compound COCCN(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cccc(Cl)c1)=O KKPGZOBSPZNVBF-UHFFFAOYSA-N 0.000 description 1
- HGILWWCUMUZSIH-UHFFFAOYSA-N O=C(CCN1CC1)N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O Chemical compound O=C(CCN1CC1)N(CC1)CCN1c(ccc(C(NCCc(ccc(Cl)c1)c1Cl)=O)c1)c1NC(c1cc(Cl)ccc1)=O HGILWWCUMUZSIH-UHFFFAOYSA-N 0.000 description 1
- HMXBPLQWGXADLM-UHFFFAOYSA-N O=C(c(cc1)cc(NC(c2cc(Cl)ccc2)=O)c1N1CCC2(CNCC2)CC1)NCCc(ccc(Cl)c1)c1Cl Chemical compound O=C(c(cc1)cc(NC(c2cc(Cl)ccc2)=O)c1N1CCC2(CNCC2)CC1)NCCc(ccc(Cl)c1)c1Cl HMXBPLQWGXADLM-UHFFFAOYSA-N 0.000 description 1
- VXKVXJNXOWZNQL-UHFFFAOYSA-N O=C(c(cc1)cc(NC(c2cccc(Cl)c2)=O)c1N(CC1)CCC1N1CCCCC1)NCCc(cc1)ccc1Cl Chemical compound O=C(c(cc1)cc(NC(c2cccc(Cl)c2)=O)c1N(CC1)CCC1N1CCCCC1)NCCc(cc1)ccc1Cl VXKVXJNXOWZNQL-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
- C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
- C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/20—Spiro-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Pyridine Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2973808P | 2008-02-19 | 2008-02-19 | |
| US61/029,738 | 2008-02-19 | ||
| PCT/US2009/034340 WO2009105435A1 (en) | 2008-02-19 | 2009-02-18 | Inhibitors of the chemokine receptor cxcr3 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102007108A true CN102007108A (zh) | 2011-04-06 |
Family
ID=40527535
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009801138321A Pending CN102007108A (zh) | 2008-02-19 | 2009-02-18 | 趋化因子受体CxCR3的抑制剂 |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8268828B2 (enExample) |
| EP (1) | EP2262784B1 (enExample) |
| JP (1) | JP2011512412A (enExample) |
| KR (1) | KR20100123835A (enExample) |
| CN (1) | CN102007108A (enExample) |
| AR (1) | AR070430A1 (enExample) |
| AU (1) | AU2009215643A1 (enExample) |
| BR (1) | BRPI0908815A2 (enExample) |
| CA (1) | CA2715557A1 (enExample) |
| CL (1) | CL2009000368A1 (enExample) |
| CO (1) | CO6241113A2 (enExample) |
| CR (1) | CR11604A (enExample) |
| DO (1) | DOP2010000254A (enExample) |
| EC (1) | ECSP10010409A (enExample) |
| IL (1) | IL207597A0 (enExample) |
| MA (1) | MA32191B1 (enExample) |
| MX (1) | MX2010008397A (enExample) |
| NI (1) | NI201000132A (enExample) |
| NZ (1) | NZ587380A (enExample) |
| PE (1) | PE20091576A1 (enExample) |
| RU (1) | RU2010138577A (enExample) |
| SV (1) | SV2010003648A (enExample) |
| TW (1) | TW200948791A (enExample) |
| WO (1) | WO2009105435A1 (enExample) |
| ZA (1) | ZA201005314B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107072205A (zh) * | 2014-09-10 | 2017-08-18 | Epizyme股份有限公司 | Smyd抑制剂 |
| CN115974766A (zh) * | 2023-01-04 | 2023-04-18 | 中国药科大学 | N-苄基-3-苯基酰胺类衍生物、包含其的药物组合物及其应用 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20091576A1 (es) | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
| EP2424840B1 (en) | 2009-04-27 | 2014-08-06 | Boehringer Ingelheim International GmbH | Cxcr3 receptor antagonists |
| WO2011084985A1 (en) * | 2010-01-07 | 2011-07-14 | Boehringer Ingelheim International Gmbh | Cxcr3 receptor antagonists |
| KR101251788B1 (ko) | 2010-12-06 | 2013-04-08 | 기아자동차주식회사 | 차량 연비 정보 단말표시 시스템 및 그 방법 |
| ES2649995T3 (es) | 2011-07-18 | 2018-01-16 | Merck Patent Gmbh | Benzamidas |
| EP2601950A1 (en) | 2011-12-06 | 2013-06-12 | Sanofi | Cycloalkane carboxylic acid derivatives as CXCR3 receptor antagonists |
| WO2013106409A1 (en) | 2012-01-10 | 2013-07-18 | Merck Patent Gmbh | Benzamide derivatives as modulators of the follicle stimulating hormone |
| CN104093715B (zh) | 2012-02-02 | 2017-04-26 | 埃科特莱茵药品有限公司 | 4‑(苯并咪唑‑2‑基)‑噻唑化合物及相关氮杂衍生物 |
| EP2666769A1 (en) | 2012-05-23 | 2013-11-27 | Sanofi | Substituted B-amino acid derivatives as CXCR3 receptor antagonist |
| MX363432B (es) | 2013-07-22 | 2019-03-22 | Idorsia Pharmaceuticals Ltd | Derivados 1-(piperazin-1-il)-2-([1,2,4]triazol-1-il)-etanona. |
| AR099789A1 (es) | 2014-03-24 | 2016-08-17 | Actelion Pharmaceuticals Ltd | Derivados de 8-(piperazin-1-il)-1,2,3,4-tetrahidro-isoquinolina |
| EA032927B1 (ru) | 2015-01-15 | 2019-08-30 | Идорсия Фармасьютиклз Лтд | Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора |
| AR103399A1 (es) | 2015-01-15 | 2017-05-10 | Actelion Pharmaceuticals Ltd | Derivados de (r)-2-metil-piperazina como moduladores del receptor cxcr3 |
| FI3600312T3 (fi) * | 2017-03-26 | 2023-07-25 | Takeda Pharmaceuticals Co | Piperidinyyli- ja piperatsinyylisubstituoituja heteroaromaattisia karboksamideja gpr6:n modulaattoreina |
| CN116410159B (zh) * | 2023-06-09 | 2023-08-22 | 济南国鼎医药科技有限公司 | 一种恩曲替尼中间体的制备方法及其应用 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3719660A (en) | 1969-06-13 | 1973-03-06 | Takeda Chemical Industries Ltd | 2-furfurylthioinosine-5'-phosphate compounds |
| US3840556A (en) | 1971-05-28 | 1974-10-08 | Lilly Co Eli | Penicillin conversion by halogen electrophiles and anti-bacterials derived thereby |
| US6124319A (en) | 1997-01-21 | 2000-09-26 | Merck & Co., Inc. | 3,3-disubstituted piperidines as modulators of chemokine receptor activity |
| US6469002B1 (en) | 2001-04-19 | 2002-10-22 | Millennium Pharmaceuticals, Inc. | Imidazolidine compounds |
| US6794379B2 (en) | 2001-06-06 | 2004-09-21 | Tularik Inc. | CXCR3 antagonists |
| GB0203994D0 (en) | 2002-02-20 | 2002-04-03 | Celltech R&D Ltd | Chemical compounds |
| US20050272936A1 (en) | 2002-06-03 | 2005-12-08 | Axten Jeffrey M | Imidazolium cxcr3 inhibitors |
| US6734659B1 (en) | 2002-06-13 | 2004-05-11 | Mykrolis Corporation | Electronic interface for use with dual electrode capacitance diaphragm gauges |
| EP1853587B1 (en) * | 2005-02-16 | 2011-08-03 | Schering Corporation | Novel heterocyclic substituted pyridine or phenyl compounds with cxcr3 antagonist activity |
| WO2006088919A2 (en) | 2005-02-16 | 2006-08-24 | Schering Corporation | Pyridyl and phenyl substituted piperazine-piperidines with cxcr3 antagonist activity |
| KR20070107060A (ko) | 2005-02-16 | 2007-11-06 | 쉐링 코포레이션 | Ｃｘｃｒ3 길항제 활성을 갖는 피라지닐 치환된피페라진-피페리딘 |
| US20080312215A1 (en) * | 2005-06-28 | 2008-12-18 | Pharmacopeia Drug Discovery, Inc. | Substituted [1,4]-diazepanes as CXCR3 antagonists and their use in the treatment of inflammatory disorders |
| ES2382163T3 (es) | 2005-10-11 | 2012-06-05 | Schering Corporation | Compuestos heterocíclicos sustituidos con actividad antagonista de CXCR3 |
| WO2007064553A2 (en) | 2005-11-29 | 2007-06-07 | Merck & Co., Inc. | Thiazole derivatives as cxcr3 receptor modulators |
| AU2007227425A1 (en) | 2006-03-21 | 2007-09-27 | Pharmacopeia, Inc. | Heterocyclic substituted pyridine compounds with CXCR3 antagonist activity |
| CN101516869A (zh) | 2006-07-14 | 2009-08-26 | 先灵公司 | 具有cxcr3拮抗剂活性的杂环取代的哌嗪化合物 |
| PE20091576A1 (es) | 2008-02-19 | 2009-11-05 | Sanofi Aventis | DERIVADOS DE 3-(AMIDO O SULFAMIDO)-4-(4-AZINIL SUSTITUIDO)BENZAMIDA COMO INHIBIDORES DEL RECEPTOR DE QUIMIOQUINAS CxCR3 |
-
2009
- 2009-02-17 PE PE2009000232A patent/PE20091576A1/es not_active Application Discontinuation
- 2009-02-18 CN CN2009801138321A patent/CN102007108A/zh active Pending
- 2009-02-18 MX MX2010008397A patent/MX2010008397A/es not_active Application Discontinuation
- 2009-02-18 BR BRPI0908815A patent/BRPI0908815A2/pt not_active IP Right Cessation
- 2009-02-18 JP JP2010547712A patent/JP2011512412A/ja active Pending
- 2009-02-18 AU AU2009215643A patent/AU2009215643A1/en not_active Abandoned
- 2009-02-18 AR ARP090100561A patent/AR070430A1/es not_active Application Discontinuation
- 2009-02-18 CL CL2009000368A patent/CL2009000368A1/es unknown
- 2009-02-18 WO PCT/US2009/034340 patent/WO2009105435A1/en not_active Ceased
- 2009-02-18 KR KR1020107018467A patent/KR20100123835A/ko not_active Withdrawn
- 2009-02-18 EP EP09711984.6A patent/EP2262784B1/en active Active
- 2009-02-18 RU RU2010138577/04A patent/RU2010138577A/ru not_active Application Discontinuation
- 2009-02-18 CA CA2715557A patent/CA2715557A1/en not_active Abandoned
- 2009-02-18 NZ NZ587380A patent/NZ587380A/en not_active IP Right Cessation
- 2009-02-19 TW TW098105199A patent/TW200948791A/zh unknown
-
2010
- 2010-07-26 ZA ZA2010/05314A patent/ZA201005314B/en unknown
- 2010-07-28 CR CR11604A patent/CR11604A/es not_active Application Discontinuation
- 2010-07-29 NI NI201000132A patent/NI201000132A/es unknown
- 2010-08-06 US US12/852,076 patent/US8268828B2/en active Active
- 2010-08-12 IL IL207597A patent/IL207597A0/en unknown
- 2010-08-18 DO DO2010000254A patent/DOP2010000254A/es unknown
- 2010-08-18 SV SV2010003648A patent/SV2010003648A/es not_active Application Discontinuation
- 2010-08-18 EC EC2010010409A patent/ECSP10010409A/es unknown
- 2010-08-19 CO CO10102315A patent/CO6241113A2/es not_active Application Discontinuation
- 2010-09-13 MA MA33173A patent/MA32191B1/fr unknown
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107072205A (zh) * | 2014-09-10 | 2017-08-18 | Epizyme股份有限公司 | Smyd抑制剂 |
| CN115974766A (zh) * | 2023-01-04 | 2023-04-18 | 中国药科大学 | N-苄基-3-苯基酰胺类衍生物、包含其的药物组合物及其应用 |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009215643A1 (en) | 2009-08-27 |
| BRPI0908815A2 (pt) | 2019-09-24 |
| WO2009105435A1 (en) | 2009-08-27 |
| CA2715557A1 (en) | 2009-08-27 |
| ZA201005314B (en) | 2011-03-30 |
| CO6241113A2 (es) | 2011-01-20 |
| TW200948791A (en) | 2009-12-01 |
| EP2262784B1 (en) | 2014-04-16 |
| SV2010003648A (es) | 2011-01-31 |
| US8268828B2 (en) | 2012-09-18 |
| PE20091576A1 (es) | 2009-11-05 |
| EP2262784A1 (en) | 2010-12-22 |
| ECSP10010409A (es) | 2010-09-30 |
| CL2009000368A1 (es) | 2009-06-26 |
| MA32191B1 (fr) | 2011-04-01 |
| NI201000132A (es) | 2011-03-16 |
| KR20100123835A (ko) | 2010-11-25 |
| NZ587380A (en) | 2011-09-30 |
| CR11604A (es) | 2010-10-05 |
| MX2010008397A (es) | 2010-08-23 |
| DOP2010000254A (es) | 2010-08-31 |
| AR070430A1 (es) | 2010-04-07 |
| RU2010138577A (ru) | 2012-03-27 |
| IL207597A0 (en) | 2010-12-30 |
| JP2011512412A (ja) | 2011-04-21 |
| US20100305088A1 (en) | 2010-12-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8268828B2 (en) | Inhibitors of the chemokine receptor CxCR3 | |
| US11155532B2 (en) | Cyclopropylamines as LSD1 inhibitors | |
| US8178535B2 (en) | Substituted sulfonamide compounds having bradykinin 1 receptor activity and use thereof as medicaments | |
| KR20100087291A (ko) | 케모카인 수용체 길항제로서의 옥타하이드로펜탈렌 화합물 | |
| NO329228B1 (no) | Indoliziner som kinaseinhibitorer | |
| AU2008329072A1 (en) | Aryl and heteroaryl fused imidazo (1,5-A) pyrazines as inhibitors of phosphodiesterase 10 | |
| JP2010531364A (ja) | ピペラジニルオキソアルキルテトラヒドロ−β−カルボリンおよび関連類似体 | |
| JP2005507918A (ja) | 肥満治療用のｍｃｈアンタゴニスト | |
| CN102341400A (zh) | 用作激酶抑制剂的吡咯并嘧啶化合物 | |
| US20090186899A1 (en) | Substituted Sulfonamide Compounds | |
| CN103339108A (zh) | 蛋白酶激活受体2(par2)拮抗剂 | |
| EA038796B1 (ru) | Индолиноновые соединения и их применение в лечении фиброзных заболеваний | |
| EP4357339A1 (en) | Sulfoximide substituted indazole irak4 kinase inhibitor, preparation method therefor, and use thereof | |
| CN100374440C (zh) | 用于治疗肥胖的作为选择性黑色素浓缩激素受体拮抗剂的螺取代的哌啶化合物 | |
| US20100240670A1 (en) | 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application | |
| KR102803907B1 (ko) | 멜라노코르틴 수용체 작용제 화합물의 결정형 ⅲ 및 이의 제조방법 | |
| KR101158568B1 (ko) | 신경발생을 자극 및 신경 퇴화를 억제하는 방법 및 조성물 | |
| CN116396284A (zh) | 苯并七元氮氧杂环吲哚-2-甲酰胺衍生物及其制备方法和用途 | |
| TW201930311A (zh) | 蕈毒鹼型乙醯膽鹼受體m4之正向別構調節劑 | |
| CN102656162A (zh) | 新颖的(杂环/四氢吡啶)-(哌嗪基)-1-烷酮和(杂环/二氢吡咯烷)-(哌嗪基)-1-烷酮衍生物及其作为p75抑制剂的用途 | |
| WO2025119380A1 (zh) | 雌激素受体调节剂及其用途 | |
| WO2025140364A1 (zh) | 一种稠合嘧啶环化合物、药物组合物及其应用 | |
| JPWO2004026874A1 (ja) | トリアザスピロ［５．５］ウンデカン誘導体の新規結晶 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110406 |